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Due to increased travel, climatic, and environmental changes, the incidence of tick-borne
disease in both humans and animals is increasing throughout Europe. Therefore, extended
surveillance tools are desirable. To accurately screen tick-borne pathogens (TBPs), a large
scale epidemiological study was conducted on 7050 Ixodes ricinus nymphs collected from
France, Denmark, and the Netherlands using a powerful new high-throughput approach.
This advanced methodology permitted the simultaneous detection of 25 bacterial, and
12 parasitic species (including; Borrelia, Anaplasma, Ehrlichia, Rickettsia, Bartonella,
Candidatus Neoehrlichia, Coxiella, Francisella, Babesia, and Theileria genus) across 94
samples. We successfully determined the prevalence of expected (Borrelia burgdorferi
sensu lato, Anaplasma phagocytophilum, Rickettsia helvetica, Candidatus Neoehrlichia
mikurensis, Babesia divergens, Babesia venatorum), unexpected (Borrelia miyamotoi),
and rare (Bartonella henselae) pathogens in the three European countries. Moreover
we detected Borrelia spielmanii, Borrelia miyamotoi, Babesia divergens, and Babesia
venatorum for the first time in Danish ticks. This surveillance method represents a major
improvement in epidemiological studies, able to facilitate comprehensive testing of TBPs,
and which can also be customized to monitor emerging diseases.
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INTRODUCTION
In Europe, ticks are the most important vectors of human and
animal infectious diseases, and transmit more pathogens than any
other arthropod (Jongejan and Uilenberg, 2004; Colwell et al.,
2011). These diseases are normally maintained in stable nat-
ural cycles involving ticks, wildlife, and/or domestic animals,
whereas humans are accidental hosts (De La Fuente et al., 2008).
Ixodes ricinus is the most widespread and abundant European
tick species capable of transmitting several diseases of both med-
ical and veterinary importance (Heyman et al., 2010). Ixodes
ricinus has the greatest impact on human public health by trans-
mitting Lyme borreliosis etiological agents, caused by at least
four Borrelia genospecies in Europe: Borrelia burgdorferi sensu
stricto, Borrelia garinii, Borrelia afzelii, and Borrelia spielmanii.
The relapsing fever spirochete, Borrelia miyamotoi, is transmitted
by the same Ixodes species and has recently been described in ticks
as well as in a human case from the Netherlands (Hovius et al.,
2013). In addition to Borrelia transmission, Ixodes ricinus can
transmit many other pathogens, including: Anaplasma spp. such
as Anaplasma phagocytophilum, Rickettsia spp. from the spotted
fever group, Candidatus Neoehrlichia mikurensis, Ehrlichia spp.,
Bartonella spp., Francisella tularensis, andCoxiella burnetii (Parola
and Raoult, 2001; Cotte et al., 2008; Fertner et al., 2012). Ticks can
also transmit Babesia genus protozoa, such as Babesia divergens or
the newly described Babesia venatorum (sp. EU1) and Theileria
spp. (Bishop et al., 2004; Bonnet et al., 2007a).
Increased human travel, animal transport, and environmen-
tal changes are responsible for the emergence and/or spread
of numerous tick-borne pathogens (TBPs) in Europe (Dantas-
Torres et al., 2012). Therefore, effective tick-based surveillance
is essential for monitoring human and/or animal disease emer-
gence (Diuk-Wasser et al., 2014). Ticks harbor a variety of
pathogens, some of which are obligate intracellular organisms
and/or are impossible to artificially culture. Consequently, molec-
ular approaches are thus indispensable for TBP identification.
In conventional amplification-based assays, TBP detection occurs
for a restricted number of target pathogens known to be trans-
mitted by certain tick species collected at particular sites (Cotte
et al., 2010). Themain disadvantage of this approach is the limited
number of different targets that can be tested, given the quantity
Frontiers in Cellular and Infection Microbiology www.frontiersin.org July 2014 | Volume 4 | Article 103 | 1
CELLULAR AND INFECTION MICROBIOLOGY
Michelet et al. Surveillance of multiple tick-borne pathogens
of DNA required for one PCR. To improve surveillance of human
and animal diseases, new investigative tools are required which
perform high-throughput testing of a wider panel of TBPs.
Therefore, the aim of this study was to conduct high-
throughput monitoring of tick-borne human and animal
pathogens in Europe. Accordingly, we developed a novel high-
throughput epidemiological surveillance method to identify both
major and neglected European TBPs (bacteria and parasites). This
tool utilizes a microfluidic system (BioMark™ dynamic array sys-
tem, Fluidigm) that is capable of performing parallel real-time
PCRs using either 96.96 chips or 48.48 chips resulting in either
9216 or 2304 individual reactions, respectively (Liu et al., 2003).
In a single experiment, 94 ticks or pools of ticks can be tested for
the presence of 25 bacteria and 12 parasites, as well as confirma-
tion of the tick species. As only a few microliters of sample are
required for each test, this system can also be used in conjuction
with the typically low-volume DNA extracts prepared from ticks.
Then we applied this method to screen 7050 Ixodes ricinus col-
lected from three European countries; France, Denmark, and the
Netherlands. We demonstrated increased surveillance efficiency
of major and neglected TBPs, and improved monitoring of the
emerging diseases important to public and animal health.
MATERIALS AND METHODS
STUDY AREA AND TICK COLLECTION
A total of 7050 Ixodes ricinus nymphs, from six different locations
in France, Denmark, and the Netherlands, divided in 47 pools of
25 nymphs per site, were studied. Questing nymphs were collected
using the flagging technique (Vassallo et al., 2000). In France,
ticks were collected from Murbach (F1) (N 47◦ 55′, E 7◦ 9′) and
Wasselonne (F2) (N 48◦ 37′, E 7◦ 27′) in 2011. In Denmark, ticks
were collected from Vestskoven (D1) (N 55◦ 42′, E 12◦ 21′) and
Grib Skov (D2) (N 56◦ 02′, E 12◦ 20′) in 2012. In the Netherlands,
ticks were collected from the Duin en Kruidberg area (N1) (N 52◦
17′, E 4◦ 49′) in 2010 and 2011, and from the Austerlitz area (N2)
(N 52◦ 5′, E 5◦ 18′) over a period from 2008 to 2012.
DNA EXTRACTION
Ticks were morphologically identified to species level (Pérez-
Eid, 2007) and preserved at −80◦C. After washing once in 70%
ethanol for 5min and twice in distilled water for 5min, pools of
25 nymphs were crushed in 300µl of DMEM with 10% fetal calf
serum and six steel balls using the homogenizer Precellys®24 Dual
(Bertin, France) at 5500 rpm for 20 s.
DNA was then extracted using the Wizard genomic DNA
purification kit (Promega, France). Total DNA per sample was
eluted in 50µl of rehydration solution and stored at −20◦C until
further use.
PRIMERS AND PROBE DESIGN
Pathogens, targeted genes and primers/probe sets are listed in
Table 1. For each pathogen or tick, primers and probes were
specifically designed for this study. Each primer or probe set was
validated on dilution range of several positive controls (Table 1)
and real-time TaqMan PCRs on a LightCycler® 480 (LC480)
(Roche Applied Science, Germany). Real-time PCR assays were
performed in a final volume of 12µl using the LightCycler® 480
Probe Master Mix 1× (Roche Applied Science, Germany), with
primers and probes at 200 nM and 2µl of control DNA. Thermal
cycling conditions were as follows: 95◦C for 5min, 45 cycles at
95◦C for 10 s and 60◦C for 15 s and one final cooling cycle at
40◦C for 10 s. Four pathogens (Borrelia valaisiana, Francisella
tularensis, Coxiella burnetii, and Theileria annulata) were tar-
geted by real-time PCRs on two different sequences to improve
detection.
DNA PRE-AMPLIFICATION
For DNA pre-amplification, the TaqMan PreAmp Master Mix
(Applied Biosystems, France) was used according to the manufac-
turer’s instructions. Primers (except those which target tick DNA)
were pooled combining equal volume of primers (200 nM final
each). The reaction was performed in a final volume of 5µl con-
taining 2.5µl TaqMan PreAmpMasterMix, 1.2µl pooled primers
mix and 1.3µl DNA, with one cycle at 95◦C for 10min, 14 cycles
at 95◦C for 15 s and 4min at 60◦C. At the end of the cycling pro-
gram the reactions were diluted 1:10. Pre-amplified DNAs were
stored at −20◦C until needed.
HIGH-THROUGHPUT REAL-TIME PCR SYSTEM
The BioMark™ real-time PCR system (Fluidigm, USA) was used
for high-throughput microfluidic real-time PCR amplification
using either the 96.96 or the 48.48 dynamic arrays (Fluidigm).
These chips dispense 96 (or 48) PCRmixes and 96 (or 48) samples
into individual wells, after which on-chip microfluidics assemble
PCR reactions in individual chambers prior to thermal cycling
resulting in either 9216 or 2304 individual reactions.
Amplifications were performed using 6-carboxyfluorescein
(FAM)- and black hole quencher (BHQ1)-labeled TaqMan probes
with TaqMan Gene expression master mix in accordance with
manufacturer’s instructions (Applied Biosystems, France). A 6µl
sample mix was prepared per sample, containing 3µl TaqMan®
Gene expression Master Mix (Applied Biosystems, Foster City,
CA), 0.3µl sample Loading Reagent (Fluidigm PN 85000746) and
2.7µl of diluted pre-amplified DNA. A TaqMan® primer assay
was prepared for each target, containing 18µM of each primer
and 4µM of probe. Three microliters of these primer assays were
mixed with equal volumes of Dynamic Array (DA) assay load-
ing reagent (Fluidigm PN 85000736) to make assay mixes (9µM
primers and 2µM probe). Prior to loading the samples and assay
mixes into the inlets, the chip was primed in the IFC Controller
HX apparatus. Five µl of sample mixes, prepared as described,
were then loaded into each sample inlet of the dynamic array chip
and 5µl of assay mixes were loaded into assay inlets. The chip
was then placed on the IFC Controller HX for loading and mix-
ing. After approximately 45min the chip was ready for thermal
cycling and detection of the reaction products on the Biomark.
PCR cycling comprised of 2min at 50◦C, 10min at 95◦C, followed
by 40 cycles of 2-step amplification of 15 s at 95◦C, and 1min
at 60◦C. Data were acquired on the BioMark™ Real-Time PCR
System and analyzed using the Fluidigm Real-time PCR Analysis
software to obtain crossing point (CP) values.
For microfluidic tool evaluation on field samples, the assays
were performed in duplicate. Two negative water controls were
included per chip. Ixodes ricinusDNA served to confirm the tested
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Table 1 | List of pathogens, tick species, targets, primers/probe sets, and positive controls.
Species Target Name Sequence Length (bp) Positive control
Borrelia burgdorferi
sensu stricto
rpoB Bo_bu_rpoB_F GCTTACTCACAAAAGGCGTCTT 83 Culture of B31 strain
Bo_bu_rpoB_R GCACATCTCTTACTTCAAATCCT
Bo_bu_rpoB_P AATGCTCTTGGACCAGGAGGACTTTCA
Borrelia garinii rpoB Bo_ga_rpoB_F TGGCCGAACTTACCCACAAAA 88 Culture of NE11 strain
Bo_ga_rpoB_R ACATCTCTTACTTCAAATCCTGC
Bo_ga_rpoB_P TCTATCTCTTGAAAGTCCCCCTGGTCC
Borrelia afzelii fla Bo_af_fla_F GGAGCAAATCAAGATGAAGCAAT 116 Culture of VS641 strain
Bo_af_fla_R TGAGCACCCTCTTGAACAGG
Bo_af_fla_P TGCAGCCTGAGCAGCTTGAGCTCC
Borrelia valaisiana ospE Bo_val_ospE_F GAAACTTAGGGAGTATCTTATGAAT 143 Culture of VS116 strain
Bo_val_ospE_R CTTGCCCCCTTAAACTAATATCT
Bo_val_ospE_P TGCTCACTCAACCTGCCTTGCTCGC
ospA Bo_va_ospA_F ACTCACAAATGACAGATGCTGAA 135
Bo_va_ospA_R GCTTGCTTAAAGTAACAGTACCT
Bo_va_ospA_P TCCGCCTACAAGATTTCCTGGAAGCTT
Borrelia miyamotoi glpQ B_miya_glpQ_F CACGACCCAGAAATTGACACA 94 Plasmida
B_miya_glpQ_R GTGTGAAGTCAGTGGCGTAAT
B_miya_glpQ_P TCGTCCGTTTTCTCTAGCTCGATTGGG
Borrelia spielmanii fla Bo_spi_fla_F ATCTATTTTCTGGTGAGGGAGC 71 Plasmida
Bo_spi_fla_R TCCTTCTTGTTGAGCACCTTC
Bo_spi_fla_P TTGAACAGGCGCAGTCTGAGCAGCTT
Borrelia lusitaniae rpoB Bo_lus_rpoB_F CGAACTTACTCATAAAAGGCGTC 87 Culture of Poti-B1 strain
Bo_lus_rpoB_R TGGACGTCTCTTACTTCAAATCC
Bo_lus_rpoB_P TTAATGCTCTCGGGCCTGGGGGACT
Borrelia bissettii rpoB Bo_bi_rpoB_F GCAACCAGTCAGCTTTCACAG 118 Plasmida
Bo_bi_rpoB_R CAAATCCTGCCCTATCCCTTG
Bo_bi_rpoB_P AAAGTCCTCCCGGCCCAAGAGCATTAA
Borrelia spp. 23S rRNA Bo_bu_sl_23S_F GAGTCTTAAAAGGGCGATTTAGT 73
Bo_bu_sl_23S_R CTTCAGCCTGGCCATAAATAG
Bo_bu_sl_23S_P AGATGTGGTAGACCCGAAGCCGAGT
Anaplasma marginale msp1b An_ma_msp1_F CAGGCTTCAAGCGTACAGTG 85 Experimentally infected cow
An_ma_msp1_R GATATCTGTGCCTGGCCTTC
An_ma_msp1_P ATGAAAGCCTGGAGATGTTAGACCGAG
Anaplasma platys groEL An_pla_groEL_F TTCTGCCGATCCTTGAAAACG 75 Infected dog blood
An_pla_groEL_R CTTCTCCTTCTACATCCTCAG
An_pla_groEL_P TTGCTAGATCCGGCAGGCCTCTGC
Anaplasma ovis msp4 An_ov_msp4_F TCATTCGACATGCGTGAGTCA 92 Plasmida
An_ov_msp4_R TTTGCTGGCGCACTCACATC
An_ov_msp4_P AGCAGAGAGACCTCGTATGTTAGAGGC
Anaplasma centrale groEL An_cen_groEL_F AGCTGCCCTGCTATACACG 79 Plasmida
An_cen_groEL_R GATGTTGATGCCCAATTGCTC
An_cen_groEL_P CTTGCATCTCTAGACGAGGTAAAGGGG
(Continued)
Frontiers in Cellular and Infection Microbiology www.frontiersin.org July 2014 | Volume 4 | Article 103 | 3
Michelet et al. Surveillance of multiple tick-borne pathogens
Table 1 | Continued
Species Target Name Sequence Length (bp) Positive control
Anaplasma
phagocytophilum
msp2 An_ph_msp2_F GCTATGGAAGGCAGTGTTGG 77 Infected embrionary cells of
Ixodes scapularisAn_ph_msp2_R GTCTTGAAGCGCTCGTAACC
An_ph_msp2_P AATCTCAAGCTCAACCCTGGCACCAC
Ehrlichia ruminantium dsb Eh_ru_dsb_F CTCAGAGGGTAATAGATTTACTC 107 Culture of Gardel strain
Eh_ru_dsb_R GTATGCAATATCTTCAAGCTCAG
Eh_ru_dsb_P ACTACAGGCCAAGCACAAGCAGAAAGA
Ehrlichia canis dsb Eh_ca_dsb_F AATACTTGGTGAGTCTTCACTCA 110 Plasmida
Eh_ca_dsb_R GTTGCTTGTAATGTAGTGCTGC
Eh_ca_dsb_P AAGTTGCCCAAGCAGCACTAGCTGTAC
Ehrlichia chaffeensis dsb Eh_ch_dsb_F TATTGCTAATTACCCTCAAAAAGTC 117 Infected wild Amblyomma
americanumEh_ch_dsb_R GAGCTATCCTCAAGTTCAGATTT
Eh_ch_dsb_P ATTGACCTCCTAACTAGAGGGCAAGCA
Candidatus
Neoehrlichia mikurensis
groEL Neo_mik_groEL_F AGAGACATCATTCGCATTTTGGA 96 Infected tick
Neo_mik_groEL_R TTCCGGTGTACCATAAGGCTT
Neo_mik_groEL_P AGATGCTGTTGGATGTACTGCTGGACC
Rickettsia conorii 23S-5S ITS Ri_co_ITS_F CTCACAAAGTTATCAGGTTAAATAG 118 Culture
Ri_co_ITS_R CGATACTCAGCAAAATAATTCTCG
Ri_co_ITS_P CTGGATATCGTGGCAGGGCTACAGTAT
Rickettsia slovaca 23S-5S ITS Ri_slo_ITS_F GTATCTACTCACAAAGTTATCAGG 138 Culture
Ri_slo_ITS_R CTTAACTTTTACTACAATACTCAGC
Ri_slo_ITS_P TAATTTTCGCTGGATATCGTGGCAGGG
Rickettsia massiliae 23S-5S ITS Ri_ma_ITS_F GTTATTGCATCACTAATGTTATACTG 128 Culture
Ri_ma_ITS_R GTTAATGTTGTTGCACGACTCAA
Ri_ma_ITS_P TAGCCCCGCCACGATATCTAGCAAAAA
Rickettsia helvetica 23S-5S ITS Ri_he_ITS_F AGAACCGTAGCGTACACTTAG 79 Culture
Ri_he_ITS_R GAAAACCCTACTTCTAGGGGT
Ri_he_ITS_P TACGTGAGGATTTGAGTACCGGATCGA
Spotted fever group gltA SFG_gltA_F CCTTTTGTAGCTCTTCTCATCC 145
SFG_gltA_R GCGATGGTAGGTATCTTAGCAA
SFG_gltA_P TGGCTATTATGCTTGCGGCTGTCGGT
Bartonella henselae pap31 Bar_he_pap31_F CCGCTGATCGCATTATGCCT 107 Culture of Berlin 1 strain
Bar_he_pap31_R AGCGATTTCTGCATCATCTGCT
Bar_he_pap31_P ATGTTGCTGGTGGTGTTTCCTATGCAC
Bartonella quintana bqtR Bar_qu_bqt_F TCCATCACAAGATCTCCGCG 80 Culture
Bar_qu_bqt_R CGTGCCAATGCTCGTAACCA
Bar_qu_bqt_P TTTAAGAGAGGAGGTAGAAGAGGCTCC
Francisella tularensis tul4 Fr_tu_tul4_F ACCCACAAGGAAGTGTAAGATTA 76 Culture of CIP 5612T strain
Fr_tu_tul4_R GTAATTGGGAAGCTTGTATCATG
Fr_tu_tul4_P AATGGCAGGCTCCAGAAGGTTCTAAGT
fopA Fr_tu_fopA_F GGCAAATCTAGCAGGTCAAGC 91
Fr_tu_fopA_R CAACACTTGCTTGAACATTTCTAG
Fr_tu_fopA_P AACAGGTGCTTGGGATGTGGGTGGTG
(Continued)
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Table 1 | Continued
Species Target Name Sequence Length (bp) Positive control
Coxiella burnettii idc Co_bu_icd_F AGGCCCGTCCGTTATTTTACG 74 Culture
Co_bu_icd_R CGGAAAATCACCATATTCACCTT
Co_bu_icd_P TTCAGGCGTTTTGACCGGGCTTGGC
IS1111 Co_bu_IS111_F TGGAGGAGCGAACCATTGGT 86
Co_bu_IS111_R CATACGGTTTGACGTGCTGC
Co_bu_IS111_P ATCGGACGTTTATGGGGATGGGTATCC
Babesia divergens hsp70 Bab_di_hsp70_F CTCATTGGTGACGCCGCTA 83 Culture of RFS strain
Bab_di_hsp70_R CTCCTCCCGATAAGCCTCTT
Bab_di_hsp70_P AGAACCAGGAGGCCCGTAACCCAGA
Babesia caballi Rap1 Ba_cab_rap1_F GTTGTTCGGCTGGGGCATC 94 Plasmida
Ba_cab_rap1_R CAGGCGACTGACGCTGTGT
Ba_cab_rap1_P TCTGTCCCGATGTCAAGGGGCAGGT
Babesia canis 18S rRNA Ba_ca_RNA18S_F TGGCCGTTCTTAGTTGGTGG 104 Infected dog blood
Ba_ca_RNA18S_R AGAAGCAACCGGAAACTCAAATA
Ba_ca_RNA18S_P ACCGGCACTAGTTAGCAGGTTAAGGTC
Babesia vogeli hsp70 Ba_vo_hsp70_F TCACTGTGCCTGCGTACTTC 87 Infected dog blood
Ba_vo_hsp70_R TGATACGCATGACGTTGAGAC
Ba_vo_hsp70_P AACGACTCCCAGCGCCAGGCCAC
Babesia venatorum (sp.
EU1)
18S rRNA Bab_EU_RNA18S_F GCGCGCTACACTGATGCATT 91 Plasmida
Bab_EU_RNA18S_R CAAAAATCAATCCCCGTCACG
Bab_EU_RNA18S_P CATCGAGTTTAATCCTGTCCCGAAAGG
Babesia microti CCTeta Bab_mi_CCTeta_F ACAATGGATTTTCCCCAGCAAAA 145 Culture of R1 strain
Bab_mi_CCTeta_R GCGACATTTCGGCAACTTATATA
Bab_mi_CCTeta_P TACTCTGGTGCAATGAGCGTATGGGTA
Babesia bovis CCTeta Ba_bo_CCTeta_F GCCAAGTAGTGGTAGACTGTA 100 Culture of MO7 strain
Ba_bo_CCTeta_R GCTCCGTCATTGGTTATGGTA
Ba_bo_CCTeta_P TAAAGACAACACTGGGTCCGCGTGG
Babesia bigemina 18S rRNA Ba_big_RNA18S_F ATTCCGTTAACGAACGAGACC 99 Plasmida
Ba_big_RNA18S_R TTCCCCCACGCTTGAAGCA
Ba_big_RNA18S_P CAGGAGTCCCTCTAAGAAGCAAACGAG
Babesia major CCTeta Ba_maj_CCTeta_F CACTGGTGCGCTGATCCAA 75 Plasmida
Ba_maj_CCTeta_R TCCTCGAAGCATCCACATGTT
Ba_maj_CCTeta_P AACACTGTCAACGGCATAAGCACCGAT
Babesia ovis 18S rRNA Ba_ov_RNA18S_F TCTGTGATGCCCTTAGATGTC 92 Plasmida
Ba_ov_RNA18S_R GCTGGTTACCCGCGCCTT
Ba_ov_RNA18S_P TCGGAGCGGGGTCAACTCGATGCAT
Theileria equi ema1 Th_eq_ema1_F GGCTCCGGCAAGAAGCACA 66 Plasmida
Th_eq_ema1_R CTTGCCATCGACGACCTTGA
Th_eq_ema1_P CTTCAAGGCTCCAGGCAAGCGCGT
Theileria annulata 18S rRNA Th_an_18S_F GCGGTAATTCCAGCTCCAATA 126 Culture of D7 strain
Th_an_18S_R AAACTCCGTCCGAAAAAAGCC
Th_an_18S_P ACATGCACAGACCCCAGAGGGACAC
Tams1 Th_an_Tams1_F CGATTACAAACCAGTTGTCGAC 82
Th_an_Tams1_R GTAAAGGACTGATGAGAAGACG
Th_an_Tams1_P TGAGTACTGAGGCGAAGACTGCAAGG
(Continued)
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Table 1 | Continued
Species Target Name Sequence Length (bp) Positive control
Ixodes ricinus ITS2 Ix_ri_ITS2_F CGAAACTCGATGGAGACCTG 77 Tick
Ix_ri_ITS2_R ATCTCCAACGCACCGACGT
Ix_ri_ITS2_P TTGTGGAAATCCCGTCGCACGTTGAAC
Ixodes persulcatus ITS2 Ix_pe_ITS2_F TGCGTTGCGTCTTCTCTTGTT 111 Tick
Ix_pe_ITS2_R TCGATAAAACCAGGTAGGAGGA
Ix_pe_ITS2_P TTTCGGAGCAAGTACAGAGGGAGCAAA
Ixodes hexagonus ITS2 Ix_hex_ITS2_F CCGCCGTTGGGATTTACGA 90 Tick
Ix_hex_ITS2_R GTTCCTCCGACCCACTTTC
Ix_hex_ITS2_P AGCGCCTTAAAAGAATCGGCAACCTCT
Dermacentor
reticulatus
ITS2 De_re_ITS2_F AACCCTTTTCCGCTCCGTG 83 Tick
De_re_ITS2_R TTTTGCTAGAGCTCGACGTAC
De_re_ITS2_P TACGAAGGCAAACAACGCAAACTGCGA
Dermacentor
marginatus
ITS2 De_ma_ITS2_F GCACGTTGCGTTGTTTGCC 139 Tick
De_ma_ITS2_R CCGCTCCGCGCAAGAATCT
De_ma_ITS2_P TTCGGAGTACGTCGAGCTCTAGCAGA
Escherichia coli eae eae-F2 CATTGATCAGGATTTTTCTGGTGATA 102 Culture of EDL933 strain
eae-R CTCATGCGGAAATAGCCGTTA
eae-P ATAGTCTCGCCAGTATTCGCCACCAATACC
aPlasmids are recombinant pBluescript IISK+ containing the target gene.
tick species and as a DNA extraction control. To determine if fac-
tors present in the sample could inhibit the PCR, Escherichia coli
strain EDL933 DNAwas added to each sample as an internal inhi-
bition control. Primers and probe specific for the E. coli eae gene
(Nielsen and Andersen, 2003) were used for an internal control.
VALIDATION OF THE RESULTS BY PCR AND SEQUENCING
Conventional PCR using primers targeting different genes or
regions than those of the BioMark™ system (Table 2), were
used to confirm the presence of pathogenic DNA in the field
samples. Amplicons were sequenced by Eurofins MWG Operon
(Germany), and then assembled using BioEdit software (Ibis
Biosciences, Carlsbad). An online BLAST (National Center for
Biotechnology Information) was used to compare results with
published sequences listed in GenBank sequence databases.
PREVALENCE ESTIMATION
Prevalences were estimated assuming perfect sensitivity and
specificity of pathogen detection using the online statistical pro-
gram “Pooled prevalence for fixed pool size and perfect test”
Method 2 (AusVet Animal Health Service http://epitools.ausvet.
com.au/content.php?page=home). Point estimates were based
on the maximum likelihood method developed by Kline et al.
(1989). Exact 95% confidence intervals were obtained by assum-
ing binomial distribution for the number of positive pools
(Cowling et al., 1999). If all pools were positive, prevalence was
recorded as >14.3%, as the highest prevalence that can be distin-
guished from 100% when testing 47 pools of 25 ticks. If all pools
were negative, prevalence was recorded as<0.25%, since the 95%
probability of sampling n negative ticks from a population with
prevalence p is given as (1 − p)n.
RESULTS
IMPLEMENTATION OF HIGH-THROUGHPUT REAL-TIME PCR SYSTEM
TO DETECT TBPs
Primers and probes were specially designed to detect 37 TBPs
and 4 tick species (Table 1). Each set of primers and probes
specifically identified their corresponding positive control sam-
ples via Taqman real-time PCRs on a LightCycler 480 apparatus.
Resulting CP values varied from 8 to 40 depending on sam-
ple type. Among the 37 TBP DNAs used as positive controls,
10 were not detected by the BioMark™ system. Consequently,
an initial step of DNA pre-amplification was added, which
enabled detection of all positive controls. Subsequently all tick
DNA samples were pre-amplified prior to pathogen detection
on the BioMark™ system. The specificity of each primer set
was then evaluated using 37 TBPs, and 4 tick species positive
controls (Figure 1). Results demonstrated high specificity for
each primers/probe set after pre-amplification, using a cut-off
of 30 CP (Figure 1). Indeed, 45 assays were only positive for
the corresponding positive control. Three assays showed cross-
reactivity with other pathogen targets. The assay for B. burgdorferi
sensu stricto cross-reacted with B. garinii and B. valaisiana DNA.
The assay targeting R. conorii cross-reacted with R. massiliae, as
well as with R. slovaca DNA, cross-reactivity was also observed
reciprocally.
LARGE SCALE PREVALENCE STUDY OF TBPs
A total of 7050 nymphs, in 47 pools of 25, from six different
European sites were tested using the BioMark™ system. Among
the targeted pathogens, 15 bacteria (B. lusitaniae, B. bissettii,
A. marginale, A. platys, A. ovis, A. centrale, E. ruminantium,
E. canis, E. chaffeensis, R. conorii, R. slovaca, R. massiliae,
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Table 2 | Primers used to confirm the presence of pathogenic DNA in ticks.
Pathogen Targeted gene Primer name Sequence (5′ → 3′) Amplicon size References
(bp)
Borrelia spp. clpA clpAF1240 GATAGATTTCTTCCAGACAAAG 975 Margos et al., 2008
clpAR2214 TTCATCTATTAAAAGCTTTCCC
clpAF1255 GACAAAGCTTTTGATATTTTAG 850
clpAR2104 CAAAAAAAACATCAAATTTTCTATCTC
Bartonella spp. 16S-23S IGS P-bhenfa TCTTCGTTTCTCTTTCTTCA 186 Rampersad et al., 2005
P-benr1 CAAGCGCGCGCTCTAACC
N-bhenf1a GATGATCCCAAGCCTTCTGGC 149
N-benr AACCAACTGAGCTACAAGCC
Anaplasma phagocytophilum msp4 MSP4AP5 ATGAATTACAGAGAATTGCTTGTAGG 849 De La Fuente et al., 2005
MSP4AP3 TTAATTGAAAGCAAATCTTGCTCCTATG
Candidatus N. mikurensis groEL NM 1152as TTCTACTTTGAACATTTGAAGAATTACTAT 1024 Diniz et al., 2011
NM 128s AACAGGTGAAACACTAGATAAGTCCAT
Rickettsia spp. gltA Rsfg877 GGGGGCCTGCTCACGGCGG 381 Regnery et al., 1991
Rsfg1258 ATTGCAAAAAGTACAGTGAACA
Babesia spp. 18S rRNA BabGF2 GYYTTGTAATTGGAATGATGG 559 Bonnet et al., 2007b
BabGR2 CCAAAGACTTTGATTTCTCTC
B. quintana, F. tularensis, and C. burnetii) and 10 parasites
(B. caballi, B. canis, B. vogeli, B. microti, B. bovis, B. bigemina,
B. major, B. ovis, T. equi, and T. annulata) were not detected in
any country. The number of positive pools for each pathogen is
presented in Table 3 and the prevalence was estimated at each site
of collection (Table 4).
In order to confirm the results obtained on the BioMark™
system and to validate this new method, classical PCR and
sequencing were performed on extracted DNA for a subset of field
samples. All sequences showed at least 99% identity with refer-
ence sequences (Table 5), and have been deposited in GenBank
(Accession numbers; KF447526-KF447532, and KF679796). Due
to primers which can only detect Borrelia and Babesia at the
genus level, only those samples which tested positive for a single
species (and not potentially co-infected samples) were confirmed
(Table 2).
France
Among the seven genospecies of Borrelia burgdorferi s.l., four
were detected in both French sites. Borrelia afzelii is the domi-
nant genospecies with a prevalence of 1.8% in F2, as previously
described (Beytout et al., 2007). The other genospecies (B. garinii,
B. valaisiana, and B. spielmanii) had prevalence rates of under
1%. B. burgdorferi s.s. was only detected in F2 at low preva-
lence (0.1%). The relapsing fever spirochete B. miyamotoi was
detected in both sites, with very different prevalences (2.5% in
F1 and 0.9% in F2) and was the most abundant Borrelia species
in F1. This spirochete has already been detected in France, but
only in female adult ticks (Reis et al., 2011). Anaplasma phago-
cytophilum was more abundant in F2 (1.2%) and its estimated
prevalence is in accordance with a previous study (Beytout et al.,
2007). Candidatus N. mikurensis was more abundant in F1
(1.3%). This pathogen has already been described in bank voles
in France (Vayssier-Taussat et al., 2012) but this is the first esti-
mation of its prevalence in French ticks. Rickettsia helvetica was
the only Rickettsiaceae identified in this study and was detected in
46/47 pools, showing the highest prevalence (14.3%) of all tested
pathogens, much higher than data reported in the literature (1.4–
6%) (Cotte et al., 2010). Bartonella henselae was only detected in
F2 (0.1%), in a single pool. Among all assessed parasitic species,
Babesia venatorum was the only parasite detected in France with a
low prevalence (0.2 and 0.3%) as previously described (Reis et al.,
2011).
Denmark
Five genospecies of B. burgdorferi s.l. were detected in Danish
ticks, four previously described (Skarphedinsson et al., 2007;
Vennestrom et al., 2008) and one, B. spielmanii, detected for
the first time. In previous studies, B. afzelii was the most preva-
lent genospecies (Skarphedinsson et al., 2007; Vennestrom et al.,
2008). In our study, B. afzelii was the most prevalent (14.3%)
in D1, while B. garinii was the most abundant (5.7%) in D2.
B. burgdorferi s.s. was detected in both sites with similar preva-
lences (4.2% and 3.8%), as well as B. valaisiana, and B. spielmanii
(approximately 1%). B. lusitaniae was identified in a previous
study (Vennestrom et al., 2008), but was not encountered in the
present study. Relapsing fever-causing B. miyamotoi was detected
for the first time in Danish I. ricinus with variable prevalences
between the two sites (1.3% inD1 and 0.2% inD2). The estimated
prevalence of A. phagocytophilum was approximately 30 times
higher in D2 (11.9%) than in D1 (0.4%) whereas its prevalence
was estimated at 15% in a previous study (Skarphedinsson et al.,
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FIGURE 1 | BioMark™ dynamic array system specificity test (48.48
chip). Each square corresponds to a single real-time PCR reaction,
where rows indicate the pathogen in the positive control and
columns represent the targets of each primers/probe set. CP values
for each reaction are indicated by color; the corresponding color
scale is presented in the legend on the right. The darkest shade
of blue and black squares are considered as negative reactions
with CP > 30.
2007). Candidatus N. mikurensis was detected with a low preva-
lence in the Danish sites (1% in D1 and 0.2% in D2) in agreement
with a previous report (Fertner et al., 2012). Rickettsia helvetica
is the only species of Rickettsia spp. reported in Denmark. This
bacterium was respectively identified in 44 and 46 pools of the
samples, corresponding to high prevalences of 10.4% in D1 and
14.3% in D2. In previous reports, the prevalence of R. hel-
vetica appeared to vary considerably, ranging from 1.4 to 13%
(Svendsen et al., 2009; Kantso et al., 2010). Two parasitic species
were found for the first time in the Danish samples, B. divergens
(0.1% in D1 and D2) and B. venatorum (1.4% in D1 and 0.5%
in D2). These parasites have never previously been reported in
Danish ticks until now, even if B. divergens is frequently found in
cattle.
The Netherlands
Five genospecies of B. burgdorferi s.l. were detected in Dutch
ticks. B. garinii and B. afzelii were the more abundant genospecies
while the other genospecies (B. burgdorferi, B. valaisiana, and
B. spielmanii) were found less frequently, as previously described
(Tijsse-Klasen et al., 2011; Sprong et al., 2012a). B. garinii and
B. afzelii were detected with equal prevalences in N1 (2.2%)
and variable prevalences in N2 (1.8 and 5.6%, respectively). The
prevalence of B. burgdorferi s.s. was estimated at 1.4 and 0.5%
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Table 3 | Number of positive pools of ticks out of the 47 tested, for two sites in France, Denmark, and the Netherlands using the microfluidic
tool (BioMark™ system).
Number of positive pools (out of 47 tested)
France Denmark The Netherlands
Murbach F1 Wasselonne F2 Vestskoven D1 Grib Skov D2 Duin en Kruidberg N1 Austerlitz N2
Borrelia spp. 32 33 47 40 38 44
B. burgdorferi sensu stricto 0 1 31 29 14 6
B. garinii 5 8 19 36 20 17
B. afzelii 13 17 46 32 20 36
B. valaisiana 1 1 13 11 6 1
B. spielmanii 1 1 10 17 3 1
B. miyamotoi 22 10 13 2 20 27
B. lusitaniae 0 0 0 0 0 0
B. bissettii 0 0 0 0 0 0
Anaplasma marginale 0 0 0 0 0 0
Anaplasma platys 0 0 0 0 0 0
Anaplasma ovis 0 0 0 0 0 0
Anaplasma centrale 0 0 0 0 0 0
Anaplasma phagocytophilum 8 12 4 45 10 19
Ehrlichia ruminantium 0 0 0 0 0 0
Ehrlichia canis 0 0 0 0 0 0
Ehrlichia chaffeensis 0 0 0 0 0 0
Candidatus N. mikurensis 13 2 10 2 28 41
Spotted fever group 46 46 44 47 45 32
Rickettsia conorii 0 0 0 0 0 0
Rickettsia slovaca 0 0 0 0 0 0
Rickettsia massiliae 0 0 0 0 0 0
Rickettsia helvetica 46 46 44 46 45 32
Bartonella henselae 0 1 0 0 0 0
Bartonella quintana 0 0 0 0 0 0
Francisella tularensis 0 0 0 0 0 0
Coxiella burnetii 0 0 0 0 0 0
Babesia divergens 0 0 1 1 0 2
Babesia caballi 0 0 0 0 0 0
Babesia canis 0 0 0 0 0 0
Babesia vogeli 0 0 0 0 0 0
Babesia venatorum (sp. EU1) 2 3 14 5 0 9
Babesia microti 0 0 0 0 0 0
Babesia bovis 0 0 0 0 0 0
Babesia bigemina 0 0 0 0 0 0
Babesia major 0 0 0 0 0 0
Babesia ovis 0 0 0 0 0 0
Theileria equi 0 0 0 0 0 0
Theileria annulata 0 0 0 0 0 0
Bold values represent pathogens detected at least in one site.
in N1 and N2, respectively. B. valaisiana and B. spielmanii were
identified in a single pool from the N2 site, but their prevalences
were estimated at 0.5 and 0.3% in N1. In 2009, B. lusitaniae was
described at one location (Sprong et al., 2012a), but was not
encountered in the present study. The relapsing fever spirochete,
B. miyamotoi, previously identified in the Netherlands in a human
case of meningoencephalitis (Hovius et al., 2013), occurred in
both Dutch sites and was most prevalent in N2 (3.4%). In N1,
B. miyamotoi showed the same prevalence as B. garinii and
B. afzelii (2.2%). Anaplasma phagocytophilum and Candidatus N.
mikurensis were found in both sites with variable prevalences,
both more abundant in N2 (2 and 7.9%, respectively). The esti-
mated prevalence of R. helvetica was highly variable depending
on the sites (11.9% in N1 and 4.5% in N2). These three bacte-
ria are well recognized in Dutch ticks and have previously been
reported in the Netherlands (Nijhof et al., 2007; Sprong et al.,
2009; Tijsse-Klasen et al., 2011). Two parasitic species were found
in Dutch ticks but were only observed in N2, B. divergens (0.2%)
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Table 4 | Estimated prevalence of pathogens detected in Ixodes ricinus in France, Denmark, and the Netherlands.
Estimated prevalence % (95% CI)
France Denmark The Netherlands
Murbach F1 Wasselonne F2 Vestskoven D1 Grib Skov D2 Duin en Kruidberg N1 Austerlitz N2
Borrelia spp. 4.47 (2.97–6.41) 4.73 (3.15–6.77) >14.27b 7.33 (4.92–10.52) 6.40 (4.31–9.12) 10.42 (6.73–15.85)
B. burgdorferi sensu stricto <0.25a 0.09 (0.00–0.48) 4.22 (2.79–6.08) 3.77 (2.46–5.47) 1.40 (0.76–2.36) 0.54 (0.20–1.18)
B. garinii 0.45 (0.14–1.05) 0.74 (0.32–1.46) 2.05 (1.22–3.21) 5.64 (3.79–8.04) 2.19 (1.32–3.39) 1.78 (1.02–2.85)
B. afzelii 1.29 (0.68–2.20) 1.78 (1.02–2.85) 14.27 (8.35–26.0) 4.47 (2.97–6.41) 2.19 (1.32–3.39) 5.64 (3.79–8.04)
B. valaisiana 0.09 (0.00–0.48) 0.09 (0.00–0.48) 1.29 (0.68–2.20) 1.06 (0.52–1.90) 0.54 (0.20–1.18) 0.09 (0.00–0.48)
B. spielmanii 0.09 (0.00–0.48) 0.09 (0.00–0.48) 0.95 (0.45–1.75) 1.78 (1.02–2.85) 0.26 (0.05–0.77) 0.09 (0.00–0.48)
B. miyamotoi 2.49 (1.54–3.79) 0.95 (0.45–1.75) 1.29 (0.68–2.20) 0.17 (0.02–0.63) 2.19 (1.32–3.39) 3.36 (2.17–4.93)
Anaplasma phagocytophilum 0.74 (0.32–1.46) 1.17 (0.60–2.05) 0.36 (0.10–0.91) 11.86 (7.42–18.97) 0.95 (0.45–1.75) 2.05 (1.22–3.21)
Candidatus N. mikurensis 1.29 (0.68–2.20) 0.17 (0.02–0.63) 0.95 (0.45–1.75) 0.17 (0.02–0.63) 3.56 (2.31–5.19) 7.90 (5.28–11.41)
Spotted fever group 14.27 (8.35–26.0) 14.27 (8.35–26.0) 10.42 (6.73–15.85) >14.27b 11.86 (7.42–18.97) 4.47 (2.97–6.41)
Rickettsia helvetica 14.27 (8.35–26.0) 14.27 (8.35–26.0) 10.42 (6.73–15.85) 14.27 (8.35–26.0) 11.86 (7.42–18.97) 4.47 (2.97–6.41)
Bartonella henselae <0.25a 0.09 (0.00–0.48) <0.25a <0.25a <0.25a <0.25a
Babesia divergens <0.25a <0.25a 0.09 (0.00–0.48) 0.09 (0.00–0.48) <0.25a 0.17 (0.02–0.63)
Babesia venatorum (sp. EU1) 0.17 (0.02–0.63) 0.26 (0.05–0.77) 1.40 (0.76–2.36) 0.45 (0.14–1.05) <0.25a 0.85 (0.38–1.60)
aAll pools negative; ball pools positive. Point estimates were based on the maximum likelihood method developed by Kline et al. (16). If all pools were positive,
prevalence was recorded as >14.3%, as the highest prevalence that can be distinguished from 100% when testing 47 pools of 25 ticks. If all pools were negative,
prevalence was recorded as <0.25%, since the 95% probability of sampling n negative ticks from a population with prevalence p is given as (1−p)n.
Table 5 | Homology between deposited sequences and reference sequences in GenBank.
Species Nb of samples Nb of samples obtained Deposited Length Percentage of Reference
tested after sequencing sequence (bp) identity (%) sequence
Borrelia garinii 1 1 KF447529 822 99 AB555782
Borrelia afzelii 1 1 KF447528 824 99 JX971251
Bartonella henselae 1 1 KF679796 149 100 FJ832091
Anaplasma phagocytophilum 12 3 KF447526 824 100 EF067343
Candidatus N. mikurensis 12 8 KF447527 1012 100 EU810407
Rickettsia helvetica 12 9 KF447530 382 100 JX040636
Babesia divergens 3 2 KF447531 527 99 AY572456
Babesia venatorum (sp. EU1) 13 10 KF447532 562 100 JQ993425
and B. venatorum (0.8%) with prevalence rates similar to previ-
ous reports (0.07 and 0.4% for B. divergens and 0.9 and 1.2% for
B. venatorum) (Nijhof et al., 2007; Wielinga et al., 2009).
DISCUSSION
In this study, we implemented a method using multiple
primers/probe sets able to perform high-throughput detection of
TBPs on an unprecedented scale. This large-scale investigation
has (i) enabled the detection of rare pathogens such as Bartonella
henselae and (ii) generated prevalence estimations for frequent,
rare, or unexpected pathogens, thus creating a comprehensive
overview of the epidemiological situation for 37 bacteria and par-
asites present in I. ricinus, in six European sites (two in France,
Denmark, and the Netherlands).
Initial testing of the BioMark™ system showed that some
pathogens could not be detected. Indeed, assessment was per-
formed on positive DNA controls extracted from cultures, animal
blood, ticks, or plasmids, therefore DNA quality and concentra-
tion were highly variable between samples. An initial step of pre-
amplification was therefore added to specifically amplify targeted
pathogen sequences. Regarding the three non-specific assays, two
hypotheses can be made: either lack of specificity or potential co-
infection of the DNA samples. As positive controls were isolated
from pure bacterial cultures, only non-specific cross-reaction
explains the lack of specificity. The set of primers and probe
designed against B. burgdorferi s.s. cross-reacted with B. garinii
and B. valaisiana. However, this cross-reaction did not occur for
every field sample. Cross-reactions were also observed between
R. conorii and R. slovaca. There was a difference of approximately
10 cycles between the CP values for the expected Rickettsia species
and the cross-reacting species. It will be interesting to test both
sets of primers and probe on DNA extracted from ticks uniquely
infected with each of the Rickettsia. However, this issue is not
likely to arise with field samples, as R. slovaca is transmitted
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by Dermacentor marginatus and R. conorii by Rhipicephalus san-
guineus. In conclusion, the primers and probe sets for B. burgdor-
feri s.s.,R. conorii, andR. slovaca need further optimization, so the
current results obtained for these species should be interpreted
with care. Several of the targeted pathogens cannot be cultured,
or are rare and consequently unavailable from field samples,
therefore plasmids containing target sequences were used as posi-
tive controls. For these pathogens and associated primers/probe
sets, further evaluation of specificity is required. This tool was
developed for epidemiologic rather than diagnostic purposes,
therefore detection limits and sensitivity have not been experi-
mentally determined. These experiments are somewhat difficult
to implement and require a gold standard for each pathogen and
consistent positive controls, which are not available for all TBPs.
Two sites per country were studied for the field investigation.
The technique permitted the detection of 10 bacterial species;
B. burgdorferi s.s., B. garinii, B. afzelii, B. valaisiana, B. spielmanii,
B. miyamotoi, A. phagocytophilum, Candidatus N. mikurensis,
R. helvetica, B. henselae, and two parasitic species; B. divergens,
and B. venatorum, with variable prevalences according to the
site of collection. Taken together, the estimated prevalences for
all pathogens obtained on pools of 25 nymphs in this study are
mostly consistent with European published data. For future stud-
ies, it will be fascinating to investigate smaller nymph pools to
obtain more accurate estimations of TBP prevalences. The preva-
lence of B. miyamotoi is reported for the first time in Denmark at
two sites and is quite similar between the three European coun-
tries in our study. Borrelia miyamotoi is transmitted by the same
Ixodes species as the etiologic agents of European Lyme borrelio-
sis, and has been detected in Ixodes ticks in Europe (Richter et al.,
2003). Up until now no human cases have been reported in France
or Denmark, but our data and the recent case of human infec-
tion described in the Netherlands (Hovius et al., 2013) suggest
that surveillance needs to be improved. Candidatus N. mikuren-
sis was detected in all three countries, with the highest prevalence
in the Netherlands. Several human cases have been reported over
the past decade in Europe (Maurer et al., 2013). However, clin-
ical symptoms are not pathognomonic, suggesting the existence
of unreported cases due to reduced awareness of symptoms by
public health professionals (Jahfari et al., 2012). As this emerg-
ing human pathogen is widespread in Europe, it requires careful
monitoring. Rickettsia helvetica was described as the most preva-
lent pathogen in all three countries. Even if its pathogenicity
remains unclear, R. helvetica has been implicated in the develop-
ment of fatal perimyocarditis (Sprong et al., 2009). Isolation of the
bacterium from a patient is needed to definitely confirm R. hel-
vetica as a human pathogen; however, R. helvetica already repre-
sents an excellent candidate for future emergence (Parola, 2004).
Over the last few years, I. ricinus has been identified as a compe-
tent vector for Bartonella henselae (Cotte et al., 2008). Little data
are available on its prevalence in ticks; and it has been estimated at
between 11 and 40% in Europe (Dietrich et al., 2010). Bartonella
henselae has never been reported in Danish ticks, but two vari-
ant types were detected in cats and mice (Engbaek and Lawson,
2004). Its presence in French ticks could be linked to the presence
of wild cats in eastern France compared to the other countries.
Babesiosis can be a variable but potentially severe disease, and is
best known as an animal affliction. However, increasing numbers
of human cases have refocused epidemiological attention on this
emerging zoonosis (Hildebrandt et al., 2013). Our study demon-
strates that these hemoparasites are widely present in European
ticks, and were observed for the first time in Danish ticks. Babesia
microti was not encountered in this study but has previously been
detected in the Netherlands at a prevalence ranging from 0.1 to
9% (Wielinga et al., 2009; Tijsse-Klasen et al., 2011).
Interestingly, among the targeted pathogens, 15 bacterial
species and 10 parasitic species were not detected in any coun-
try, leading us to conclude that they are not present in I. ricinus
from those European sites. Indeed, these TBPs are either very rare
(Parola and Raoult, 2001; Sprong et al., 2012b) or have never been
previously detected in the sampled regions, or are transmitted
by other stage or other tick species (Parola and Raoult, 2001).
Francisella tularensis and Coxiella burnetii are linked to impor-
tant human and veterinary public health problems that require
surveillance (Sprong et al., 2012b; Carvalho et al., 2014); however,
the role of ticks in the transmission of these pathogens is nonethe-
less debated. Their apparent absence across the three European
countries in I. ricinus ticks suggests that the risk of acquiring
tularemia or Q fever from questing ticks could be negligible.
This new screening approach based on microfluidic systems
allowing multiple parallel real-time PCRs, is a powerful tool for
TBP surveillance in Europe. This study demonstrates the tech-
nique’s capacity for large-scale studies utilizing the unique ability
to simultaneously analyze large numbers of samples and mul-
tiple target pathogens. As demonstrated for babesiosis, vector
surveillance could be very useful for monitoring disease emer-
gence (Diuk-Wasser et al., 2014). Compared to an array with fixed
panels of probes, this new tool presents the major advantage that
it can be easily adapted to new situations, as it is entirely possible
to add or remove primers/probe sets in order to modify the panel
of targeted pathogens and tick species. Further studies will indeed
confirm if this approach heralds the necessary breakthrough in
epidemiological surveillance of vector-borne pathogens, broad-
ening the monitoring of human and animal diseases.
In conclusion, our study clearly demonstrates the utility of
a fast tool that allows comprehensive testing of high numbers
of TBPs in ticks, and can be easily customized to fit regional
demands or to screen tick or host samples for new or emerging
diseases.
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